DUGGAN ROBERT W

CIK 00010559195 companiesHAYWARD, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001055919

Recent Transactions

50 trades

Purchase
Summit Therapeutics Inc.$SMMT
Common Stock
2026-06-12$13.12/sh+3,810,000→ 573,883,879 total
Award
PULSE BIOSCIENCES, INC.$PLSE
Stock Option (right to buy)
2026-06-11+30,000→ 30,000 total
Award
PULSE BIOSCIENCES, INC.$PLSE
Stock Option (right to buy)
2026-06-11+12,495→ 12,495 total
Purchase
Summit Therapeutics Inc.$SMMT
Common Stock
2026-06-04$14.60/sh+100,000→ 25,824,474 total
Purchase
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2026-05-11$19.69/sh+660,233→ 48,211,433 total
Purchase
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2026-05-11$19.69/sh+660,233→ 48,370,047 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2026-01-02$8.76/sh+11,232→ 11,232 total
Award
Summit Therapeutics Inc.$SMMT
Common Stock
2025-10-21$18.74/sh+266,808→ 25,724,474 total
Award
Summit Therapeutics Inc.$SMMT
Common Stock
2025-10-21$18.74/sh+13,980,789→ 570,073,879 total
Purchase
Summit Therapeutics Inc.$SMMT
Common Stock
2025-10-21$18.74/sh+26,680→ 76,680 total
Purchase
Summit Therapeutics Inc.$SMMT
Common Stock
2025-09-11$18.07/sh+5,000→ 556,093,090 total
Purchase
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2025-09-10$14.66/sh+34,659→ 47,551,200 total
Purchase
Summit Therapeutics Inc.$SMMT
Common Stock
2025-09-10$17.68/sh+333,394→ 556,088,090 total
Award
PULSE BIOSCIENCES, INC.$PLSE
Stock Option (right to buy)
2025-08-15+30,000→ 30,000 total
Award
PULSE BIOSCIENCES, INC.$PLSE
Stock Option (right to buy)
2025-08-15+20,792→ 20,792 total
Exercise/Conversion
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2025-05-30−74,545→ 0 total
Exercise/Conversion
Summit Therapeutics Inc.$SMMT
Common Stock
2025-05-30$2.64/sh+74,545→ 555,754,696 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2025-04-29+400,000→ 400,000 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2025-04-29+9,590,558→ 9,590,558 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2025-04-29+1,040,000→ 1,040,000 total
Exercise of In-Money
Summit Therapeutics Inc.$SMMT
Warrant (right to buy)
2025-04-08+3,985,055→ 0 total
Exercise of In-Money
Summit Therapeutics Inc.$SMMT
Common Stock
2025-04-08$1.58/sh+3,985,055→ 555,680,151 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2025-01-02$9.18/sh+10,724→ 10,724 total
Exercise of In-Money
PULSE BIOSCIENCES, INC.$PLSE
Warrants (right to buy)
2024-12-18−24,656→ 0 total
Exercise of In-Money
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2024-12-18$11.00/sh+5,187,824→ 47,516,541 total
Exercise of In-Money
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2024-12-18$11.00/sh+69,020→ 630,109 total
Exercise of In-Money
PULSE BIOSCIENCES, INC.$PLSE
Warrants (right to buy)
2024-12-18−2,593,912→ 0 total
Exercise of In-Money
PULSE BIOSCIENCES, INC.$PLSE
Warrants (right to buy)
2024-12-18−2,593,912→ 0 total
Exercise of In-Money
PULSE BIOSCIENCES, INC.$PLSE
Warrants (right to buy)
2024-12-18−34,510→ 0 total
Exercise of In-Money
PULSE BIOSCIENCES, INC.$PLSE
Warrants (right to buy)
2024-12-18−24,656→ 0 total
Exercise of In-Money
PULSE BIOSCIENCES, INC.$PLSE
Warrants (right to buy)
2024-12-18−34,510→ 0 total
Exercise of In-Money
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2024-12-18$11.00/sh+49,312→ 450,189 total
Purchase
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2024-12-13$17.18/sh+55,256→ 42,328,717 total
Purchase
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2024-12-12$17.13/sh+45,404→ 42,273,461 total
Purchase
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2024-12-11$16.74/sh+6,054→ 42,178,057 total
Purchase
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2024-12-11$17.42/sh+50,000→ 42,228,057 total
Purchase
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2024-09-12$14.41/sh+145,140→ 47,709,140 total
Purchase
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2024-09-11$14.77/sh+12,800→ 47,564,000 total
Award
Summit Therapeutics Inc.$SMMT
Common Stock
2024-09-11$22.70/sh+3,325,991→ 551,695,096 total
Exercise of In-Money
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2024-07-03+5,187,824→ 42,172,003 total
Purchase
PULSE BIOSCIENCES, INC.$PLSE
Warrant (right to buy)
2024-07-03+2,593,912→ 2,593,912 total
Purchase
PULSE BIOSCIENCES, INC.$PLSE
Warrant (right to buy)
2024-07-03+24,656→ 24,656 total
Purchase
PULSE BIOSCIENCES, INC.$PLSE
Warrant (right to buy)
2024-07-03+2,593,912→ 2,593,912 total
Exercise of In-Money
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2024-07-03+69,020→ 561,089 total
Exercise of In-Money
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2024-07-03+49,312→ 400,877 total
Purchase
PULSE BIOSCIENCES, INC.$PLSE
Warrant (right to buy)
2024-07-03+34,510→ 34,510 total
Purchase
PULSE BIOSCIENCES, INC.$PLSE
Warrant (right to buy)
2024-07-03+24,656→ 24,656 total
Purchase
PULSE BIOSCIENCES, INC.$PLSE
Warrant (right to buy)
2024-07-03+34,510→ 34,510 total
Award
PULSE BIOSCIENCES, INC.$PLSE
Stock Option (right to buy)
2024-06-06+16,247→ 16,247 total
Award
PULSE BIOSCIENCES, INC.$PLSE
Stock Option (right to buy)
2024-06-06+20,000→ 20,000 total

Companies

Recent Filings

Address

C/O PULSE BIOSCIENCES, INC. 3957 POINT EDEN WAY

HAYWARD, CA, 94545

View on SEC.gov